BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center for RNA Biomedicine - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://rna.umich.edu
X-WR-CALDESC:Events for Center for RNA Biomedicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20200928T090000
DTEND;TZID=America/Detroit:20200928T100000
DTSTAMP:20260414T181557
CREATED:20200817T170308Z
LAST-MODIFIED:20200922T163039Z
UID:6352-1601283600-1601287200@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Hiroaki Suga\, University of Tokyo
DESCRIPTION:“Genetic code reprogramming that Revolutionizes the discovery processes of peptide drug leads”\n\nHiroaki Suga\, PhD\nProfessor\, Department of Chemistry\, Graduate School of Science\nThe University of Tokyo\, Japan\n \nZOOM \nREGISTRATION REQUIRED: https://umich.zoom.us/webinar/register/WN_PBHPayAvR8WobaSf3z0AUA \nABSTRACT: Macrocyclic peptides possess a number of pharmacological characteristics distinct from other well-established therapeutic molecular classes\, resulting in a versatile drug modality with a unique profile of advantages. Macrocyclic peptides are accessible by not only chemical synthesis but also ribosomal synthesis. Particularly\, recent inventions of the genetic code reprogramming integrated with an in vitro display format\, referred to as RaPID (Random non-standard Peptides Integrated Discovery) system\, have enabled us to screen mass libraries (>1 trillion members) of non-standard peptides containing multiple non-proteinogenic amino acids\, giving unique properties of peptides distinct from conventional peptides\, e.g. greater proteolytic stability\, higher affinity (low nM to sub nM dissociation constants similar to antibodies)\, and superior pharmacokinetics. The field is rapidly growing evidenced by increasing interests from industrial sectors\, including small start-ups as well as mega-pharmas\, toward drug development efforts on macrocyclic peptides\, which has led to several de novo discovered peptides entering clinical trials. This lecture discusses the aforementioned screening technology involving the method of “genetic code reprogramming” powered by flexizymes\, and several showcases of therapeutic potentials of macrocyclic peptides \nJoin us for a Journal club to prepare for Dr Suga’s seminar\nSeptember 24 @ 4:00 pm – 5:00 pm\nZOOM LINK: https://umich.zoom.us/j/93910966695\nPublication to review:“Ribosomal Formation of Thioamide Bonds in Polypeptide Synthesis” Rumit Maini\, Hiroyuki Kimura\, Ryo Takatsuji\, Takayuki Katoh\, Yuki Goto\, and Hiroaki Suga https://pubs.acs.org/doi/pdf/10.1021/jacs.9b11097 \nRESEARCH INTERESTS: In the Suga lab\, our aim is to utilize organic chemistry techniques in combination with biology to tackle yet unresolved questions. In our inclusive research\, we procure scientific knowledge leading to new concepts and develop novel technologies with broad applicability\, which can extend to drug discovery. We provide a diligent and cooperative research environment with a goal of nurturing individuals so they are brimming with innovation and global-mindedness. \n  \n  \n 
URL:https://rna.umich.edu/events/seminar-hiroaki-suga-university-of-tokyo/
CATEGORIES:Journal Club,Seminar
END:VEVENT
END:VCALENDAR